91
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Clinical, endoscopical and morphological efficacy of mesalazine in patients with irritable bowel syndrome

, , , &
Pages 141-153 | Published online: 16 Jun 2011

References

  • PowellROn certain painful afflictions of the intestinal canalMed Trans Royal Coll Phys18186106107
  • LongstrethGFThompsonWGCheyWDHoughtonLAMearinFSpillerRCFunctional bowel disordersGastroenterology20061301480149116678561
  • LoginovASParfenovAIIntestinal diseasesMoscowMeditsina Publishers2000137211
  • World Global Practice Guideline Irritable Bowel Syndrome WGO42009 available at: http://www.worldgastroenterology.org/assets/downloads/en/pdf/guidelines/20_irritable_bowel_syndrome.pdf. (03/15/2009).
  • LemboAJDrossmanDAContemporary diagnosis and management of irritable bowel syndromeNewton (PA)Handbooks in Healthcare Company2002148
  • DrossmanDACreedFHOldenKWSvedlundJTonerBBWhiteheadWEPsychosocial aspects of the functional gastrointestinal disordersGut1999Suppl 211251130
  • ClouseREAlpersDHHockenberyDMDeSchryver-KecskemetiKPericrypt eosinophilic enterocolitis and chronic diarrheaGastroenterology19921031681761612324
  • DrossmanDACamilleriMMayerEAWhiteheadWEAGA Technical review on irritable bowel syndromeGastroenterology20021232108213112454866
  • MayerEAGebhardtGFBasic and clinical aspects of visceral hyperalgesiaGastroenterology19941072712938020671
  • MertzHMorganVTannerGRegional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distentionGastroenterology200011884284810784583
  • DrossmanDARingelYVogtBAAlterations of brain activity associated with resolution of emotional distress and pain in a case of severe irritable bowel syndromeGastroenterology200312475476112612913
  • BarbaraGStanghelliniVCremonCAminosalicylates and other anti-inflammatory compounds for irritable bowel syndromeDig Dis200927Suppl 111512120203507
  • BarbaraGDe GiorgioRStanghelliniVCremonCSalvioliBCorinaldesiRNew pathophysiological mechanisms in irritable bowel syndromeAliment Pharmacol Ther200420Suppl 21915335408
  • KlookerTKBraakBKoopmanKEThe mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndromeGut2010591213122120650926
  • MacsharryJO’MahonyLFanningAMucosal cytokine imbalance in irritable bowel syndromeScand J Gastroenterology20084314671476
  • ManningAPThompsonWGHeatonKWMorrisAFTowards positive diagnosis of the irritable bowelBr Med J19782653654698649
  • KruisWThiemeCWeinzhierlMSchusslerPHollJPaulusWA diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic diseaseGastroenterology198487176724251
  • ThompsonWGDotevallGDrossmanDAHeatonKWKruisWIrritable bowel syndrome: Guidelines for the diagnosisGastroenterol Int198929295
  • DrossmanDAThompsonWGTalleyNJFunch-JensenPJanssensJWhiteheadWEIdentification of subgroups of functional bowel disordersGastroenterol Int19903159172
  • DrossmanDACorazziariETalleyNJThompsonWGWhiteheadWEDiagnostic criteria for functional gastrointestinal disordersDrossmanDACorazziariETalleyNJThompsonWGWhiteheadWERome II. The functional gastrointestinal disorders. Diagnosis, Pathophysiology and Treatment: A Multinational ConsensusMcLean (VA):Degnon and Associates2000
  • PalssonOSTaubECookEIIIBurnettCKMcCommonsJJWhiteheadWEValidation of Rome Criteria for functional gastrointestinal disorders by factor analysisAm J Gastroenterol2000911996
  • VannerSJDepewWTPatersonWGPredictive value of the Rome criteria for diagnosing the irritable bowel syndromeAm J Gastroenterology19999429122917
  • SpiegelBCamilleriMBolusRPsychometric evaluation of patient-reported outcomes in irritable bowel syndrome randomized controlled trials: A Rome Foundation ReportGastroenterology20091371944195319706292
  • BarbaraGStanghelliniVCremonCDe GiorgioRCorinaldesiRWhat is the effect of inflammation on intestinal function?Inflamm Bowel Dis200814S140S14418816685
  • IsgarBHarmanMKayeMDWhorwellPJSymptoms of irritable bowel syndrome in ulcerative colitis in remissionGut1983241901926826101
  • LimsuiDPardiDSCamilleriMSymptomatic overlap between irritable bowel syndrome and microscopic colitisInflamm Bowel Dis20071317518117206699
  • SimrénMAxelssonJGillbergRAbrahamssonHSvedlundJBjörnssonESQuality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factorsAm J Gastroenterol20029738939611866278
  • SpillerRGarsedKPostinfectious irritable bowel syndromeGastroenterol200913619791988
  • BarbaraGStanghelliniVDe GiorgioRActivated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndromeGastroenterology200412669370214988823
  • CenacNAndrewsCNHolzhausenMRole for protease activity in visceral pain in irritable bowel syndromeJ Clin Invest200711763664717304351
  • AerssensJCamilleriMTalloenWAlterations in mucosal immunity identified in the colon of patients with irritable bowel syndromeClin Gastroenterol Hepatol2008619420518237869
  • O’MahonyLMcCarthyJKellyPLactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profilesGastroenterology200512854155115765388
  • TravisSPStangeEFLémannMEuropean Crohn’s and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn’s disease: current managementGut200655Suppl 1i16i3516481629
  • CorinaldesiRStanghelliniVCremonCEffect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept studyAliment Pharmacol Ther20093024525219438846